Skip to main content
. Author manuscript; available in PMC: 2023 Dec 4.
Published in final edited form as: Arthritis Care Res (Hoboken). 2022 Jan 17;74(3):484–492. doi: 10.1002/acr.24485

Table 2:

Disease Activity and Functional Status over 12 Months in Patients with RA seen by Telemedicine vs. In-Person Only

Telemedicine In-Person Only
Baseline (n=62) 6 months (n=48) 12 months (n=39) p-value Baseline (n=60) 6 months (n=40) 12 months (n=35) p-value

RAPID3, Mean (SD) 12.4 (5.3) 11.5 (5.0) 12.1 (5.7) 0.7* 10.4 (5.6) 9.8 (4.7) 10.0 (5.4) 0.50*
Low disease activity or remission, n (%) 11 (18) 10 (21) 9 (23) 0.5** 17 (28) 9 (23) 11 (31) 0.42**
Functional status score, mean (SD) 2.9 (1.9) 2.5 (1.7) 2.4 (1.8) 0.02* 1.9 (1.9) 2.1 (2.0) 1.8 (1.3) 069 *
*

repeated measures ANOVA

**

Repeated measures logistic regression